Connexion
S'inscrire
Réinitialiser le mot de passe
Publier & Distribuer
Solutions d'édition
Solutions de distribution
Thèmes
Architecture et design
Arts
Business et économie
Chimie
Chimie industrielle
Droit
Géosciences
Histoire
Informatique
Ingénierie
Intérêt général
Linguistique et sémiotique
Littérature
Mathématiques
Musique
Médecine
Pharmacie
Philosophie
Physique
Sciences bibliothécaires et de l'information, études du livre
Sciences des matériaux
Sciences du vivant
Sciences sociales
Sport et loisirs
Théologie et religion
Études classiques et du Proche-Orient ancient
Études culturelles
Études juives
Publications
Journaux
Livres
Comptes-rendus
Éditeurs
Blog
Contact
Chercher
EUR
USD
GBP
Français
English
Deutsch
Polski
Español
Français
Italiano
Panier
Home
Journaux
Radiology and Oncology
Édition 49 (2015): Edition 4 (December 2015)
Accès libre
Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
Norimitsu Kasahara
Norimitsu Kasahara
,
Hisao Imai
Hisao Imai
,
Kyoichi Kaira
Kyoichi Kaira
,
Keita Mori
Keita Mori
,
Kazushige Wakuda
Kazushige Wakuda
,
Akira Ono
Akira Ono
,
Tetsuhiko Taira
Tetsuhiko Taira
,
Hirotsugu Kenmotsu
Hirotsugu Kenmotsu
,
Hideyuki Harada
Hideyuki Harada
,
Tateaki Naito
Tateaki Naito
,
Haruyasu Murakami
Haruyasu Murakami
,
Masahiro Endo
Masahiro Endo
,
Takashi Nakajima
Takashi Nakajima
,
Masanobu Yamada
Masanobu Yamada
et
Toshiaki Takahashi
Toshiaki Takahashi
| 27 nov. 2015
Radiology and Oncology
Édition 49 (2015): Edition 4 (December 2015)
À propos de cet article
Article précédent
Article suivant
Résumé
Références
Auteurs
Articles dans cette édition
Aperçu
PDF
Citez
Partagez
Publié en ligne:
27 nov. 2015
Pages:
409 - 415
Reçu:
31 janv. 2015
Accepté:
06 juil. 2015
DOI:
https://doi.org/10.1515/raon-2015-0037
Mots clés
chemoradiotherapy
,
limited-stage disease small cell lung cancer
,
overall survival
,
post-progression survival
,
progression-free survival
© 2015 Norimitsu Kasahara et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Norimitsu Kasahara
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
Hisao Imai
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
Kyoichi Kaira
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Department of Oncology Clinical Development, Gunma University Graduate School of Medicine, Japan
Keita Mori
Clinical Trial Coordination Office, Shizuoka Cancer Center, Japan
Kazushige Wakuda
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Akira Ono
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Tetsuhiko Taira
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Hirotsugu Kenmotsu
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Hideyuki Harada
Division of Radiation Oncology, Shizuoka Cancer Center, Japan
Tateaki Naito
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Haruyasu Murakami
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan
Masahiro Endo
Division of Diagnostic Radiology, Shizuoka Cancer Center, Japan
Takashi Nakajima
Division of Diagnostic Pathology, Shizuoka Cancer Center, Japan
Masanobu Yamada
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
Toshiaki Takahashi
Division of Thoracic Oncology, Shizuoka Cancer Center, Japan